Found 68 All Conditions trials

Below is a list of actively recruiting clinical trials based on your search for "All Conditions"

18 years or above
All genders
Phase 1
Interventional
This study investigates advanced solid tumors. Participants must have cancer that has come back or did not improve with treatment. The purpose of this study is to evaluate the safety of an investigational medication in participants with solid tumors that are hard to treat or have spread throughout the body.The …
18 years - 60 years
All genders
Phase 3
Interventional
This study investigates multiple sclerosis. It looks at how different ways of giving a medicine might work for people with this condition.The study evaluates the safety and effectiveness of giving the investigational medication under the skin compared to giving it directly into a vein.Who can participate: Adults aged 18 to …
42 days - 89 days
Accepts healthy volunteer
All genders
Phase 3
The purpose of this study is to investigate a 21-valent pneumococcal conjugate vaccine in healthy infants. The study examines how infants' bodies respond to different lots of this investigational vaccine.This study evaluates the immune response and safety of the investigational vaccine compared to a licensed vaccine. It focuses on understanding …
12 years or above
Male
Phase 4
Interventional
This study investigates severe hemophilia by examining the effects of switching patients from one preventive treatment to another.The study evaluates the safety and tolerability of changing to an investigational medication after stopping the previous treatment.Who can participate: Male participants aged 12 years and older with severe hemophilia A who have …
18 years or above
All genders
Phase 2
Interventional
The purpose of this study is to investigate subcutaneous isatuximab in combination with carfilzomib and dexamethasone for people with relapsed and/or refractory multiple myeloma. This study focuses on adults who have previously received one to three lines of therapy.This study evaluates the overall response rate of the medication combination. It …
18 years or above
All genders
Phase 2
Interventional
This study investigates the effectiveness of different investigational medications compared to a placebo in improving lung capacity in participants with Interstitial Lung Disease (ILD) secondary to Systemic Sclerosis (SSc). The purpose is to observe changes from the start to the end of the treatment period at Week 52.Participants in the …
18 years - 45 years
All genders
Phase 1/2
Interventional
This study investigates a vaccine for mild acne. The purpose of this study is to evaluate how safe the vaccine is and how well it works for people with mild acne.Researchers will look at how the body responds to the vaccine. They will check if it is safe and see …
60 years or above
All genders
Phase 1/2
Interventional
This study investigates Geographic Atrophy secondary to Age-related Macular Degeneration. Participants will receive a one-time intravitreal injection of an investigational medication to evaluate its effects.The study focuses on evaluating the safety and efficacy of the investigational medication for treating Geographic Atrophy associated with Age-related Macular Degeneration.Who can participate: Participants must …
2 years - 17 years
All genders
Phase 3
Interventional
This study investigates the safety and ability of a new investigational pneumococcal vaccine to help the body make antibodies in children and adolescents with sickle cell disease.The study compares the investigational vaccine to a licensed pneumococcal vaccine. It evaluates whether the investigational vaccine is effective in producing an immune response.Who …
50 years or above
All genders
Phase 4
Interventional
This study investigates early polymyalgia rheumatica. The purpose of this study is to explore the effects of an investigational medication on this condition.Researchers will evaluate the safety and tolerability of the investigational medication. They will focus on its general effects on individuals with early polymyalgia rheumatica.Who can participate: Adults 50 …